1 / 8

Healthcare Group

Strategic Analysis of Brazilian Pharmaceutical Markets Recession Aftermath – Inflation and Volatile Exchange Rates – Affects Brazilian Pharmaceutical Market.

tiana
Download Presentation

Healthcare Group

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Strategic Analysis of Brazilian Pharmaceutical MarketsRecession Aftermath – Inflation and Volatile Exchange Rates – Affects Brazilian Pharmaceutical Market “The brunt of the irregular exchange rates of the Real against the dollar is borne by the end user – affecting consumer decisions in a price sensitive market. However, fiscal prudence will allow participants overcome these barriers to market growth.” Healthcare Group

  2. Industry Trends • Economy coming out of a recession which started in 2000 • Sales of generic drugs to drive the overall market growth • Pharmaceutical Industry is price sensitive and sales is controlled by pharmacies and drug-stores • Dependence on import of raw materials combined with foreign exchange volatility is a major problem • Companies are going into alliances for co-marketing and production

  3. Key Features • Frost & Sullivan Provides: • Detailed insights into recent developments and trends • Opportunities, challenges, and strategic demand recommendations • Analyst insights on ‘hot topics’ and emerging opportunities in the pharmaceutical markets • Market sizing and in-depth end-user analysis in the markets • Market forecasts and analysis by product type, end-user application and geographic region

  4. What We Offer • Coverage: Brazil • Proven methodology encompassing extensive primary and secondary data and research • Focused information and strategies that cover business and technology issues • Credible data and analysis highlighting industry dynamics • Winning strategies to help you create precise business plans

  5. Who Will Benefit? Current Market Participants • Find out how you compare to the competition • Assess current and future drivers and restraints • Determine and exploit market share opportunities through new end-user application demand New Entrants • Analyze challenges associated with the industry • Calculate forecasts for end-user growth potential • Position yourself to capitalize on the market’s unmet needs Investment Community • Analyze long-term strategies of test equipment companies that offer signal sources • Determine which participants will outperform the competition • Assess attractiveness of investing in the pharmaceutical markets

  6. What’s Included • Pharmaceutical market analysis and impact of variables of the economy on the market • In-depth analysis of branded pharmaceutical segment • In-depth analysis of generic drugs segment • Opportunities and strategies for new and existing companies

  7. Key Market Participants • Abbott Laboratories • Aventis • Bristol-Myers Squibb • Biosintetica • EMS Sigma Pharma • Eli Lilly • Janssen-Cilag • Merck • Medley • Novartis • Ranbaxy Laboratories

  8. For More Information • Call toll free: 877 GO FROST (877.463.7876) • Fax toll free: 888.690.3329 • E-mail: myfrost@frost.com • Visit: www.frost.com

More Related